The 20 Best Midline Lethal Granuloma Doctors Near Me in Baltimore, MD

Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads the AIDS Malignancy Consortium (AMC) site at Johns Hopkins and the AMC Translational Sciences Working Group nationally. Dr. Ambinder graduated from Harvard College with a Bachelor’s degree in biochemistry, after which he received his medical degree from the Johns Hopkins University School of Medicine before completing his residency at the Johns Hopkins Hospital. He also earned his Ph.D. in pharmacology from the Johns Hopkins University, and completed his oncology fellowship at Johns Hopkins. Within the clinic, Dr. Ambinder is active in the treatment of lymphoma and Kaposi’s sarcoma. Dr. Ambinder’s research is focused on exploring opportunities to prevent or treat cancer with viral infections. Virus-associated tumors are among the most common malignancies in certain populations and regions. For instance, Burkitt's lymphoma (EBV) and Kaposi's sarcoma (KSHV) are common in equatorial Africa, nasopharyngeal carcinoma (EBV) is common in southern Chinese populations or those with southern Chinese origins, and immunoblastic lymphomas (EBV) are common in immunocompromised patients (organ transplant recipients, AIDS patients, etc). Thus, Dr. Ambinder’s new approaches to prevention, diagnosis, and treatment stand to have a direct impact on the lives of cancer patients around the globe. Additionally, the study of how viruses can impact these tumors is important in creating model systems for the development of new approaches to cancer care. Currently, many immunotherapies target unidentified antigens, making the measurement of relevant immune responses problematic at best. However, in EBV-associated tumors the antigens are well defined, thus allowing the Ambinder lab to define the epitope-specific cellular immune responses. As a result of this breakthrough, interventions designed to alter immune response —whether they be vaccine based interventions, adoptive immunotherapy interventions, or pharmacologic interventions — may all be assessed in terms of relevant surrogate markers. Much in the same way the treatment of Hodgkin's lymphoma with radiotherapy and chemotherapy paved the way for the modern approach to cancer treatment more broadly, the treatment of EBV-associated tumors (including Hodgkin's lymphoma) may pave the way to the more generalized use of these modalities to treat a myriad of cancer types. Dr. Ambinder is rated as a Distinguished provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Ambinder is board certified in American Board Of Internal Medicine.

Dr. Lode J. Swinnen is a cancer specialist in Baltimore caring for patients with lymphoma. Dr. Swinnen received his M.B.Ch.B. degree from the University of Cape Town Medical School. He completed his residency at Presence Saint Joseph Hospital and performed a fellowship in hematology-oncology at Loyola University Stritch School of Medicine. Dr. Swinnen joined the Johns Hopkins faculty in 2002. His research interests include lymphomas and immunodeficiency-associated malignancies. Dr. Swinnen is a member of the Eastern Cooperative Oncology Group and the National Comprehensive Cancer Network. Dr. Swinnen is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Transplant. Dr. Swinnen is board certified in American Board Of Internal Medicine.

Mark Goldstein is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma. Dr. Goldstein is board certified in American Board Of Internal Medicine.

Dr. Lilja Bjork Solnes is an Assistant Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. Her areas of clinical expertise include diagnostic radiology, oncology, and nuclear medicine. Dr. Solnes serves as the director of Nuclear Medicine and Molecular Imaging as well as the director of Radiotheranostics at the Johns Hopkins School of Medicine. Dr. Solnes received her M.B.A. and M.D. degrees from Columbia University College of Physicians and Surgeons. She completed her radiology residency at Columbia University Medical Center and performed fellowships in Radiology and Neuroradiology at Columbia University. She also completed fellowships from Ohio State University Wexner Medical Center in Neuroradiology and Cornell University Medical Center in Radiology. Dr. Solnes is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Lymphofollicular Hyperplasia, and Renal Cell Carcinoma (RCC). Dr. Solnes is board certified in American Board Of Nuclear Medicine and American Board Of Radiology.

Dr. David M. Yousem is the associate dean for professional development in the Johns Hopkins Medicine Department of Radiology and Radiological Science. He specializes in neuroimaging. Dr. Yousem received his B.S. and M.D. degrees at the University of Michigan. He completed a radiology residency at Johns Hopkins and a two-year fellowship in neuroradiology at the University of Pennsylvania. He received his M.B.A. at Johns Hopkins University in 2003. Dr. Yousem's expertise spans the full gamut of neuroradiology techniques including computed tomography (CT), magnetic resonance imaging (MRI), angiography, myelography, CT guided aspirations and biopsies, functional MRI, diffusion and perfusion imaging, MR/CT angiography, and 3-D reconstructions. He is a noted authority on disorders of the brain, spine, head and neck, olfaction, cranial neuropathies and neurodegeneration. Dr. Yousem has authored or edited four books—Neuroradiology: THE REQUISITES, Head and Neck Case Review, and Radiology Business Practice: How to Succeed, and Non-Interpretive Skills Case Review, all published by Mosby/Elsevier—and has edited four journal issues. He has published over 250 peer reviewed articles over 50 chapters in books and has lectured on five continents. Dr. Yousem has an RSNA Educator Award sponsored on line course containing over 30 lectures on the Business of Medicine available to the public at https://webcast.jhu.edu/Mediasite/Catalog/Full/2facf598655b40ecaf3e7ee71698b86421. This is currently used by residency programs across the country to fulfill ACGME requirements for business of radiology content. He served as President of the American Society of Neuroradiology in 2008-2009 and as the Secretary of Treasurer of the World Federation of Neuroradiological Societies from 2011 to present. He sits on many of national radiological societies committees. Dr. Yousem has completed two marathons (best time: 3 hours, 54 minutes), a half Ironman, and a full Ironman (2.5-mile swim followed by 112-mile bike ride and then a 26-mile run) competition. Videos David M. Yousem e-Radiology Learning - Neuroradiology Pearls and Pitfalls (1 of 4) e-Radiology Learning - Neuroradiology Pearls and Pitfalls (2 of 4) e-Radiology Learning - Neuroradiology Pearls and Pitfalls (3 of 4) e-Radiology Learning - Neuroradiology Pearls and Pitfalls (4 of 4). Dr. Yousem is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Hydrocephalus, Normal Pressure Hydrocephalus, Subarachnoid Hemorrhage, Fractured Spine, and Embolectomy. Dr. Yousem is board certified in American Board Of Radiology.

Seung Lee is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Splenectomy.

Christian Okoye is a Radiation Oncologist practicing medicine in Baltimore, Maryland. Dr. Okoye is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Laryngeal Cancer, Breast Cancer, and Angiosarcoma.

Myo Min is a Hematologist and an Oncologist practicing medicine in Bel Air, Maryland. Dr. Min is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 78 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Colorectal Cancer, and Large-Cell Immunoblastic Lymphoma. Dr. Min is currently accepting new patients.

Meredith Wernick is a Radiation Oncologist practicing medicine in Frederick, Maryland. Dr. Wernick is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Prostate Cancer.

Nancy Hardy is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Hardy is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Harvey Ziessman is a Nuclear Medicine provider practicing medicine in Baltimore, Maryland. Dr. Ziessman is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. His clinical expertise encompasses Metachondromatosis, Syndactyly Cenani Lenz Type, Maffucci Syndrome, Ollier Disease, and Liver Embolization.

Everett Hart is a General Surgeon practicing medicine in Frederick, Maryland. Dr. Hart is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Palatal Myoclonus, Ozena, Nonallergic Rhinopathy, and Tinnitus.